E1A As a Tumor Suppressor Gene: Commentary Re S. Madhusudan Et Al. A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing...
Overview
Authors
Affiliations
Li Z, Yao Z, Zhang Y, Yao J, Pan Z, Chen J Med Sci Monit Basic Res. 2019; 25:113-120.
PMID: 30956277 PMC: 6475126. DOI: 10.12659/MSMBR.914811.
Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.
Jordan I, Lohr V, Genzel Y, Reichl U, Sandig V Microorganisms. 2016; 1(1):100-121.
PMID: 27694766 PMC: 5029493. DOI: 10.3390/microorganisms1010100.
Maliandi M, Mato-Berciano A, Sobrevals L, Roue G, Jose A, Fillat C Mol Cancer. 2015; 14:146.
PMID: 26227809 PMC: 4521493. DOI: 10.1186/s12943-015-0413-2.
Molecular targeted therapy in ovarian cancer: what is on the horizon?.
Kalachand R, Hennessy B, Markman M Drugs. 2011; 71(8):947-67.
PMID: 21668036 DOI: 10.2165/11591740-000000000-00000.
Yamaguchi H, Chen C, Chou C, Pal A, Bornmann W, Hortobagyi G Oncogene. 2010; 29(41):5619-29.
PMID: 20676141 PMC: 2955174. DOI: 10.1038/onc.2010.295.